Role of the intestinal microbiota and diet in the onset and progression of colorectal and breast cancers and the interconnection between both types of tumours
Sergio Ruiz-Saavedra , Aida Zapico , Sonia González , Nuria Salazar , Clara G. de los Reyes-Gavilán
Microbiome Research Reports ›› 2023, Vol. 3 ›› Issue (1) : 6
Role of the intestinal microbiota and diet in the onset and progression of colorectal and breast cancers and the interconnection between both types of tumours
Colorectal cancer (CRC) is among the leading causes of mortality in adults of both sexes worldwide, while breast cancer (BC) is among the leading causes of death in women. In addition to age, gender, and genetic predisposition, environmental and lifestyle factors exert a strong influence. Global diet, including alcohol consumption, is one of the most important modifiable factors affecting the risk of CRC and BC. Western dietary patterns promoting high intakes of xenobiotics from food processing and ethanol have been associated with increased cancer risk, whereas the Mediterranean diet, generally leading to a higher intake of polyphenols and fibre, has been associated with a protective effect. Gut dysbiosis is a common feature in CRC, where the usual microbiota is progressively replaced by opportunistic pathogens and the gut metabolome is altered. The relationship between microbiota and BC has been less studied. The estrobolome is the collection of genes from intestinal bacteria that can metabolize oestrogens. In a dysbiosis condition, microbial deconjugating enzymes can reactivate conjugated-deactivated oestrogens, increasing the risk of BC. In contrast, intestinal microorganisms can increase the biological activity and bioavailability of dietary phytochemicals through diverse microbial metabolic transformations, potentiating their anticancer activity. Members of the intestinal microbiota can increase the toxicity of xenobiotics through metabolic transformations. However, most of the microorganisms involved in diet-microbiota interactions remain poorly characterized. Here, we provide an overview of the associations between microbiota and diet in BC and CRC, considering the diverse types and heterogeneity of these cancers and their relationship between them and with gut microbiota.
Gut microbiota / diet / colorectal cancer / breast cancer / dietary fibre / polyphenol
| [1] |
|
| [2] |
Key Interdisciplinary Core Program for Colorectal Cancer. Follow-up recommendations in people with a family history of colorectal cancer not associated with hereditary syndromes. (in Spanish) Available from: https://www.astursalud.es/documents/35439/38460/2019%20Actualizaci%C3%B3n%20cribado%20familiar%20CCR%20en%20Asturias_ED03.pdf/c3e8a90d-ddcb-1ad7-7a1f-7a68cdc3903a. [Last accessed on 23 Nov 2023] |
| [3] |
Spanish Agency Against Cancer. Anatomy of colon and rectum. (in Spanish) Available from: https://www.contraelcancer.es/es/todo-sobre-cancer/tipos-cancer/cancer-colon. [Last accessed on 23 Nov 2023] |
| [4] |
National Cancer Institute. NCI dictionary of cancer terms: adenocarcinoma. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenocarcinoma. [Last accessed on 23 Nov 2023] |
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
World Cancer Research Fund/American Institute for Cancer Research. Continuous update project: diet, nutrition, physical activity and the prevention of cancer. Summary of strong evidence. Available from: https://www.wcrf.org/wp-content/uploads/2021/01/CUP-Strong-Evidence-Matrix.pdf. [Last accessed on 23 Nov 2023] |
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carbamate.IARC Monogr Eval Carcinog Risks Hum2010;96:3-1383 PMCID:PMC4781168 |
| [23] |
|
| [24] |
|
| [25] |
De Silva S, Tennekoon KH, Karunanayake EH. Interaction of gut microbiome and host microRNAs with the occurrence of colorectal and breast cancer and their impact on patient immunity.Onco Targets Ther2021;14:5115-29 PMCID:PMC8548058 |
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
Torres C, Barrios-Rodríguez R, Muñoz-Bravo C, Toledo E, Dierssen T, Jiménez-Moleón JJ. Mediterranean diet and risk of breast cancer: an umbrella review.Clin Nutr2023;42:600-8 |
| [43] |
|
| [44] |
van den Brandt PA, Schulpen M. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis.Int J Cancer2017;140:2220-31 |
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
de Kok TMCM, van Maanen JM. Evaluation of fecal mutagenicity and colorectal cancer risk.Mutat Res2000;463:53-101 |
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
|
| [136] |
|
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
|
| [147] |
|
| [148] |
|
| [149] |
van Duursen MBM, Nijmeijer SM, de Morree ES, de Jong PC, van den Berg M. Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model.Toxicology2011;289:67-73 |
| [150] |
|
| [151] |
|
| [152] |
|
| [153] |
|
| [154] |
|
/
| 〈 |
|
〉 |